While only 15-20% of human lung cancer tumors currently respond to immune checkpoint blockade, research team’s new approach was to induce the regression of about 70% of the tumors.”
Lung cancer is the leading cause of cancer-related death. Current treatments employ immunotherapy, often in combination with chemotherapy, but benefits to patients remain slight.
Hope for increasing immunotherapy efficacy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.